Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents
- 1 May 2011
- journal article
- review article
- Published by Elsevier in Advances in Chronic Kidney Disease
- Vol. 18 (3) , 188-198
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosisJournal of the American Academy of Dermatology, 2011
- Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two casesJournal of Cutaneous Pathology, 2009
- CKD Surveillance Using Laboratory Data From the Population-Based National Health and Nutrition Examination Survey (NHANES)American Journal of Kidney Diseases, 2009
- Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment—Report of 33 CasesRadiology, 2009
- Chronic inflammation and accelerated atherosclerosis as important cofactors in nephrogenic systemic fibrosis following intravenous gadolinium exposureClinical and Experimental Nephrology, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Nephrogenic Systemic Fibrosis, Gadolinium, and Iron MobilizationNew England Journal of Medicine, 2007
- The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literatureNephrology Dialysis Transplantation, 2006
- Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failureJournal of the American Academy of Dermatology, 2006
- Nephrogenic Systemic Fibrosis: The Nosological and Conceptual Evolution of Nephrogenic Fibrosing DermopathyAmerican Journal of Kidney Diseases, 2005